Why We Believe in the Board Certified Patient Advocate (BCPA)
BISA members who have earned the BCPA certification describe their experience, along with the professional and ethical benefits of additional patient advocacy education.
BISA Speaks at Session, Meets with FAS to Improve FDA Advisory Committees
BISA worked improve the FDA’s Advisory Committee process by speaking at a recent listening session, along with a post-meeting with the Federation of American Scientists to discuss next steps.
BISA Advocates on Capitol Hill for Patients Rising ‘We the Patients’
We the Patients 2024, organized by Patients Rising, featured nearly 60 advocates visiting Washington, D.C. to engage with 70 congressional offices about policy issues for people living with chronic and life-threatening illnesses.
BISA Joins Komen in D.C. to Advocate for Women Facing a Breast Cancer Diagnosis
In June 2024, BISA joined the Komen Foundation on Capitol Hill for the second time to support advocates sharing breast cancer stories with members of Congress at the Susan G. Komen Advocacy Summit.
BSCC Issues Consensus Statement on Breast Implant Capsulectomy Definitions and Management
Members of BISA collaborated to create a consensus statement on breast implant capsulectomy definitions and management as part of the Breast Surgery Collaborative Community (BSCC).
BISA Updates: May 2024 Life Letter
BISA released the May 2024 Life Letter with a recap from last month and some brief updates on what’s next.
5th World Consensus Conference on BIA-ALCL: Recap and Major Takeaways
BISA summarizes what we learned from the 5th World Consensus Conference on BIA-ALCL on April 20, 2024.
Advocate Spotlight: Krisztina Eva Sajosi
Our May featured advocate is a Krisztina, a survivor of BIA-ALCL who presented virtually at the World Consensus Conference on the rare cancer.
The Light Collective Protects Patient Rights and Data in the Digital Age
The Light Collective is an essential nonprofit supporting patients and communities in safeguarding health data in an era of technology.
BISA Founder Wins Charleston’s Best Patient Advocate Second Year in a Row
HealthLinks Magazine readers selected Maria as "Best Patient Advocate" in the Low Country for the second consecutive year.
BISA Updates: April 2024 Life Letter
Conferences, collaboration, and compassion 🌸 BISA released the April 2024 Life Letter with a recap from last month and some brief updates on what’s next.
Informed Consent: BISA Submits Comments On FDA Draft Guidance
BISA submitted public comments on the FDA’s recent draft guidance on improving the informed consent process.
Engaging with Implants: On-Campus at College of Charleston
Advocates educated students and the community at College of Charleston, utilizing games and prizes to increase engagement.
BISA Attends 5th World Consensus Conference on BIA-ALCL
BISA virtually attended the World Consensus Conference on BIA-ALCL to get the update on breast implant associated cancers and how to assist the public.
BISA Attends 60th NIH AC Meeting of Research on Women’s Health
The recent NIH advisory committee meeting provided updates and information from speakers on women’s health research.
BISA Joins Charleston Metro Chamber of Commerce
We’re proud to announce our membership to the Charleston Metro Chamber of Commerce.
Advocate Spotlight: Sherri Gorbett
Learn more about our featured advocate of the month, BISA treasurer Sherri Gorbett.
Sientra Bankruptcy Update: New Ownership, Warranty Commitments
Breast implant manufacturer Sientra has been successfully purchased at auction. Awaiting court approval, breast implant warranties will be honored by the new owners.
BISA Updates: March 2024 Life Letter
Welcoming spring! 🌷 BISA released the March 2024 Life Letter with a recap from last month and some brief updates on what’s next.
Grammy-Winner SZA Shares Why She Removed Her Breast Implants
Singer-songwriter SZA shared her reasoning behind removing her breast implants, which included dense, fibrocystic breast tissue, complications after having implants placed, and a family history of breast cancer.